WATSON 453 (Guanfacine Hydrochloride 2 mg)
Pill with imprint WATSON 453 is Orange, Round and has been identified as Guanfacine Hydrochloride 2 mg. It is supplied by Watson Pharmaceuticals.
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 453
Guanfacine Hydrochloride
- Imprint
- WATSON 453
- Strength
- 2 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-0453
- Inactive Ingredients
-
lactose anhydrous,
D&C Yellow No. 10,
FD&C Red No. 40,
povidone,
stearic acid,
microcrystalline cellulose,
aluminum oxide
Note: Inactive ingredients may vary.
Related Images for "WATSON 453"
More about guanfacine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 259 Reviews
- Drug class: antiadrenergic agents, centrally acting
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.